Gabriel Barragan
@gabrielbarragan.bsky.social
PhD student, Metelitsa Lab, Baylor College of Medicine/Texas Children's Hospital. CAR-NKT cell therapy for solid tumors. Opinions my own.
Impressive results with IL-18 armored CD19 CAR T-cells in patients that had relapsed after previous CD19 CAR-T therapy.
Treating the untreatable - "Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure" @pennmedicine.bsky.social @nejm.org www.nejm.org/doi/full/10....
May 8, 2025 at 1:19 AM
Impressive results with IL-18 armored CD19 CAR T-cells in patients that had relapsed after previous CD19 CAR-T therapy.